HFA Premium Access

Moderated Poster session 3 - Novel treatment

Event: Heart Failure 2018 & World Congress on Acute Heart Failure
Topic: Chronic Heart Failure
Session type: Moderated Posters
Date: 27 May 2018
Time: 15:45 - 16:30

Congress Session

7 presentations in this session

Prophylactic use of carvedilol to prevent ventricular dysfunction in patients with cancer treated with doxorubicin


What proportion of patients with HFrEF might be candidates for Sacubitril-Valsartan?

Speaker: Doctor T. O connor (Dublin, IE)

Heart failure patients with reduced left ventricular ejection fraction, who reached 100% target dose of beta-blockers in randomized and observational studies

Speaker: Mrs M. Oyanguren Artola (Bilbao, ES)

Metabolic response to exercise training in heart failure with preserved ejection fraction

Speaker: Doctor M. Bahls (Greifswald, DE)

Adherence to ESC guidelines after hospital admission for heart failure in 22500 Dutch patients: 2001-2015

Speaker: Mrs W. Kruik-Kolloffel (Almelo, NL)

Cardiovascular outcomes with the incretin-based therapies GLP-1 agonists and DPP-4 inhibitors in type 2 diabetes participants with and without heart failure

Speaker: Doctor S. Zheng (London, GB)

Functional and anatomical pulmonary arterial disease in patients with persistent pulmonary hypertension after left valve replacement according to the hemodynamic phenotype

Speaker: Doctor E. Peris Domingo (Barcelona, ES)

6 speakers from this session

Doctor Tim O connor

Beaumont Hospital, Dublin (Ireland)
1 presentation
0 follower

Mrs Maria Juana Oyanguren Artola

BIOCRUCES Health Research Institute, Bilbao (Spain)
1 presentation
0 follower

Doctor Martin Bahls

University Medicine of Greifswald, Greifswald (Germany)
0 follower

Mrs Willemien Kruik-Kolloffel

Twente Hospital Group, Almelo (Netherlands (The))
0 follower

Doctor Sean Zheng

King's College London, London (United Kingdom of Great Britain & Northern Ireland)
0 follower

Doctor Enrique Peris Domingo

University Hospital Vall d'Hebron, Barcelona (Spain)
0 follower

This platform is supported by

logo Novo Nordisk